Cite
Shaim H, Estrov Z, Harris D, et al. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol. 2018;8:1773doi: 10.3389/fimmu.2017.01773.
Shaim, H., Estrov, Z., Harris, D., Hernandez Sanabria, M., Liu, Z., Ruvolo, P., Thompson, P. A., Ferrajoli, A., Daher, M., Burger, J., Muftuoglu, M., Imahashi, N., Li, L., Liu, E., Alsuliman, A. S., Basar, R., Nassif Kerbauy, L., Sobieski, C., Gokdemir, E., Kondo, K., Wierda, W., Keating, M., Shpall, E. J., & Rezvani, K. (2017). The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Frontiers in immunology, 81773. https://doi.org/10.3389/fimmu.2017.01773
Shaim, Hila, et al. "The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide." Frontiers in immunology vol. 8 (2017): 1773. doi: https://doi.org/10.3389/fimmu.2017.01773
Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017. PMID: 29379494; PMCID: PMC5775272.
Copy
Download .nbib